In the Original Investigation published December 17, 2020, “Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant–Positive Non–Small Cell Lung Cancer,”1 Dr Song’s affiliation was incorrect. He is affiliated with the School of Medical Informatics, China Medical University, Shenyang, Liaoning, China. This article has been corrected.1
References
- 1.Song J, Wang L, Ng NN, et al. Development and validation of a machine learning model to explore tyrosine kinase inhibitor response in patients with stage IV EGFR variant–positive non–small cell lung cancer. JAMA Netw Open. 2020;3(12):e2030442. doi: 10.1001/jamanetworkopen.2020.30442 [DOI] [PMC free article] [PubMed] [Google Scholar]
